The agency gave an emergency use authorization to the testing assay, developed by Rutgers University, Spectrum Solutions and Accurate Diagnostic Labs, for collection of samples at home. The saliva-based test was originally authorized last month.
The test, designed at Rutgers University under a partnership with Spectrum Solutions and Accurate Diagnostic Labs, is designed to allow for broader population screening than the current, more prevalent method of nose and throat swabs.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.